liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Lysosomal membrane permeabilization during apoptosis: Involvement of Bax?
Linköping University, Department of Clinical and Experimental Medicine, Experimental Pathology. Linköping University, Faculty of Health Sciences.
Linköping University, Department of Clinical and Experimental Medicine, Experimental Pathology. Linköping University, Faculty of Health Sciences.
Linköping University, Department of Clinical and Experimental Medicine, Experimental Pathology. Linköping University, Faculty of Health Sciences.
Institute for Medical Microbiology, Immunology and Hygiene, University of Köln, Köln, Germany.
Show others and affiliations
2005 (English)In: International journal of experimental pathology (Print), ISSN 0959-9673, E-ISSN 1365-2613, Vol. 86, no 5, 309-321 p.Article in journal (Refereed) Published
Abstract [en]

Bcl-2 family members have long been known to control permeabilization of the mitochondrial membrane during apoptosis, but involvement of these proteins in lysosomal membrane permeabilization (LMP) was not considered until recently. The aim of this study was to investigate the mechanism underlying the release of lysosomal proteases to the cytosol seen during apoptosis, with special emphasis on the role of Bax. In human fibroblasts, exposed to the apoptosis-inducing drug staurosporine (STS), the release of the lysosomal protease cathepsin D to the cytosol was observed by immunocytochemistry. In response to STS treatment, there was a shift in Bax immunostaining from a diffuse to a punctate pattern. Confocal microscopy showed co-localization of Bax with both lysosomes and mitochondria in dying cells. Presence of Bax at the lysosomal membrane was confirmed by immuno-electron microscopy. Furthermore, when recombinant Bax was incubated with pure lysosomal fractions, Bax inserted into the lysosomal membrane and induced the release of lysosomal enzymes. Thus, we suggest that Bax is a mediator of LMP, possibly promoting the release of lysosomal enzymes to the cytosol during apoptosis.

Place, publisher, year, edition, pages
John Wiley & Sons, 2005. Vol. 86, no 5, 309-321 p.
Keyword [en]
Bax, cathepsins, lysosomes, lysosomal membrane permeabilization, mitochondria
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-13201DOI: 10.1111/j.0959-9673.2005.00442.xOAI: oai:DiVA.org:liu-13201DiVA: diva2:18026
Note

The previous status of this article was Manuscript and the working title was Insertion of Bax into lysosomal membranes promotes release of lysosomal proteases during apoptosis.

Available from: 2008-04-17 Created: 2008-04-17 Last updated: 2017-12-13Bibliographically approved
In thesis
1. Lysosomal Membrane Permeabilization: A Cellular Suicide Stragegy
Open this publication in new window or tab >>Lysosomal Membrane Permeabilization: A Cellular Suicide Stragegy
2008 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

In the last decade, a tremendous gain in knowledge concerning the molecular events of apoptosis signaling and execution has been achieved.

The aim of this thesis was to clarify the role of lysosomal membrane permeabilization and lysosomal proteases, cathepsins, in signaling for apoptosis. We identified cathepsin D as an important factor in staurosporine-induced human fibroblast cell death. After release to the cytosol, cathepsin D promoted mitochondrial release of cytochrome c by proteolytic activation of Bid. Cathepsin D-mediated cleavage of Bid generated two fragments with the apparent molecular mass of 15 and 19 kDa. By sequence analysis, three cathepsin D-specific cleavage sites, Phe24, Trp48, and Phe183, were identified. Moreover, we investigated the mechanism by which cathepsins escape the lysosomal compartment, and found that Bax is translocated from the cytosol to lysosomes upon staurosporine treatment. In agreement with these data, recombinant Bax triggered release of cathepsins from isolated rat liver lysosomes. Conceivably, the Bcl-2 family of proteins may govern release of pro-apoptotic factors from both lysosomes and mitochondria. The importance of lysosomal cathepsins in apoptosis signaling was studied also in oral squamous cell carcinoma cells following exposure to the redox-cycling drug naphthazarin or agonistic anti-Fas antibodies. In this experimental system, cathepsins were released to the cytosol, however, inhibition of neither cathepsin D, nor cysteine cathepsin activity suppressed cell death. Interestingly, cysteine cathepsins still appeared to be involved in activation of the caspase cascade. Cathepsins are often overexpressed and secreted by cancer cells, and it has been reported that extracellular cathepsins promote tumor growth and metastasis. Here, we propose that cathepsin B secreted from cancer cells may suppress cancer cell death by shedding of the Fas death receptor.

Defects in the regulation of apoptosis contribute to a wide variety of diseases, such as cancer, neurodegeneration and autoimmunity. Increased knowledge of the molecular details of apoptosis could lead to novel, more effective, treatments for these illnesses. This thesis emphasizes the importance of the lysosomal death pathway, which is a promising target for future therapeutic intervention.

Abstract [en]

In the last decade, a tremendous gain in knowledge concerning the molecular events of apoptosis signaling and execution has been achieved.

The aim of this thesis was to clarify the role of lysosomal membrane permeabilization and lysosomal proteases, cathepsins, in signaling for apoptosis. We identified cathepsin D as an important factor in staurosporine-induced human fibroblast cell death. After release to the cytosol, cathepsin D promoted mitochondrial release of cytochrome c by proteolytic activation of Bid. Cathepsin D-mediated cleavage of Bid generated two fragments with the apparent molecular mass of 15 and 19 kDa. By sequence analysis, three cathepsin D-specific cleavage sites, Phe24, Trp48, and Phe183, were identified. Moreover, we investigated the mechanism by which cathepsins escape the lysosomal compartment, and found that Bax is translocated from the cytosol to lysosomes upon staurosporine treatment. In agreement with these data, recombinant Bax triggered release of cathepsins from isolated rat liver lysosomes. Conceivably, the Bcl-2 family of proteins may govern release of pro-apoptotic factors from both lysosomes and mitochondria. The importance of lysosomal cathepsins in apoptosis signaling was studied also in oral squamous cell carcinoma cells following exposure to the redox-cycling drug naphthazarin or agonistic anti-Fas antibodies. In this experimental system, cathepsins were released to the cytosol, however, inhibition of neither cathepsin D, nor cysteine cathepsin activity suppressed cell death. Interestingly, cysteine cathepsins still appeared to be involved in activation of the caspase cascade. Cathepsins are often overexpressed and secreted by cancer cells, and it has been reported that extracellular cathepsins promote tumor growth and metastasis. Here, we propose that cathepsin B secreted from cancer cells may suppress cancer cell death by shedding of the Fas death receptor.

Defects in the regulation of apoptosis contribute to a wide variety of diseases, such as cancer, neurodegeneration and autoimmunity. Increased knowledge of the molecular details of apoptosis could lead to novel, more effective, treatments for these illnesses. This thesis emphasizes the importance of the lysosomal death pathway, which is a promising target for future therapeutic intervention.

Place, publisher, year, edition, pages
Linköping University Electronic Press, 2008. 105 p.
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 1055
Keyword
apoptosis, lysosomes, lysosomal membrane permeabilization, cathepsins, Bax, Bid, mitochondria, caspases
National Category
Dentistry
Identifiers
urn:nbn:se:liu:diva-11614 (URN)978-91-7393-940-9 (ISBN)
Public defence
2008-05-15, Linden, Campus US, Linköpings universitet, Linköping, 13:00 (English)
Opponent
Supervisors
Available from: 2008-04-17 Created: 2008-04-17 Last updated: 2017-08-30
2. Cathepsin D released from lysosomes mediates apoptosis
Open this publication in new window or tab >>Cathepsin D released from lysosomes mediates apoptosis
2003 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Last year (2002), the Nobel Prize in Physiology or Medicine was awarded to three scientists who have conducted pioneer research on programmed cell death. In the human body, more than a thousand billion cells are created every day, and an equal number die, thus programmed cell death, or apoptosis, is an important mechanism for maintaining tissue homeostasis and protecting against disease. Malfunctioning apoptosis is associated with many pathological conditions, for example, excess apoptosis is characteristic of AIDS, stroke, neurodegenerative diseases, and myocardinal infarction, and insufficient apoptosis is seen in autoimmune conditions and cancer. Robert Horvitz, one of the mentioned Nobel Prize Laureates, was the first to identify death genes, namely ced-3, -4, and -9 in the nematode Caenorhabditis elegans, which were later discovered to have counterparts in humans.

The aim of this thesis is to clarify the participation of lysosomes and lysosomal proteases in the initiation of apoptosis. The lysosomal enzyme cathepsin D regulates the human homologue of ced-3, which encoded the caspase family of proteases. Moreover, the human homologue of ced-9 encodes the Bcl-2 family of proteins such as Bax, which was involved in regulating the release of cathepsin D from lysosomes during apoptosis. In the present studies, apoptosis was induced by various substances, all of which first caused damage to lysosomes with ensuing release of lysosomal proteases. Fibroblasts exposed either to free radicals generated by the redox cycling quinone naphthazarin or to the kinase inhibitor staurosporine exhibited rapid translocation of cathepsin D from lysosomes to the cytosol and subsequent apoptosis. Malignant macrophages (J774 cells) and T lymphocytes (Jurkat cells) exposed to the lysosomotropic detergent sphingosine displayed early lysosomal destabilization and later apoptosis. Sphingosine also destabilized isolated lysosomes. Moreover, mimicking the translocation of cathepsin D by microinjecting cathepsin D into the cytosol induced apoptosis in fibroblasts.

In the mentioned systems, lysosomes were destabilized before mitochondrial changes occurred and caspases were activated. Furthermore, apoptosis was prevented by inhibition of cathepsin D in the naphthazarin, staurosporine, and sphingosine systems and by inhibition of cysteine proteases such as cathepsins B and L in the sphingosine system. These results emphasize that cytosolic localization of lysosomal proteases is necessary for the ability of these enzymes to induce apoptosis.

The present results also demonstrate that, during apoptosis, lysosomal membranes are destabilized by the following: (i) free-radical-mediated lipid peroxidation; (ii) pore formation through the Bcl-2 family member Bax; (iii) the impact of the lysosomotropic detergent sphingosine. All three of these events have been implicated in numerous other apoptosis systems. Accordingly, the participation of lysosomal enzymes in apoptosis may be more widespread than previously assumed. This new perspective on lysosomes as regulators of apoptosis may lead to novel treatment strategies for diseases associated with malfunctioning apoptosis.

Abstract [sv]

År 2002 fick tre forskare Nobelpriset i fysiologi eller medicin för upptäckten att celldöd kan regleras genetiskt. I en människa bildas vruje dygn mer än tusen miljarder celler, och vmje dygn dör likamånga celler. Denna balans mellan celldöd, eller apoptos, och celldelning är viktig får vävnadsstabilitet och som skydd mot sjukdomar. AIDS, stroke, hjärtinfarkt och neurodegenerativa sjukdomar är tillstånd då apoptosfrekvensen är för hög, medan sjukdomar som autoimmuna tillstånd och cancer uppkommer vid för låg apoptosfrekvens. En av nobelpristagarna, Robert Horvitz, identifierade i nematoden Ceanorhabditis elegans de första så kallade dödsgenema, ced-3, -4 och -9, och motsvarande gener visade sig finnas hos människa.

Målsättningen med denna avhandling är att klargöra vilken roll lysosamer och lysosamala enzymer har vid initiering av apoptos. Avhandlingen visar att det lysosamala enzymet cathepsin D reglerade aktivering av caspaser, den humana motsvarigheten till ced-3. Vidare kodar den humana homologen till ced-9 för Bcl-2. I denna proteinfamilj ingår även Bax, som reglerade frisättningen av cathepsin D från lysasornerna vid apoptos. Fibroblaster som exponerats för fria radikaler, genererade genom redoxcykling av naphthazarin, eller för proteinkinashämmaren staurosporin, frisatte snabbt cathepsin D från lysosamer med påföljande apoptos som resultat. Dessutom destabiliserade den lysosomotropa detergenten sphingosin lysosamer i maligna makrofager och T-celler, vilket ledde till apoptos. För att efterlikna frisättningen av cathepsin D från lysosamer till cytosolen mikroinjicerades fibroblaster med cathepsin D, vilket också inducerade apoptos. En cytosolisk lokalisering av cathepsiner verkar vara avgörande för initiering av apoptos.

I dessa cellsystem skedde den lysosamala destabiliseringen innan mitokondriella förändringar och caspasaktivering kunde detekteras. I cellsystemet med naphthazarin, staurosporin och sphingosin förhindrades apoptos då cathepsin D hämmades. Hänming av cystein-cathepsiner som t. ex. cathepsin B och L förhindrade också apoptos i sphingosinsystemet.

Avhandlingen visar att permeabilisering av lysosamala membraner kan induceras på flera olika sätt: (i) genom lipidperoxidering medieract av fria radikaler, (ii) genom generering av porer via Bcl-2-medlemmen Bax, (iii) via effekten av den lysosomotropa detergenten sphingosin. Dessa tre fenomen finns alla representerade som signalvägar i många apoptossystem. Följaktligen kan deltagande av lysosamala enzym vid apoptos vara långt mer generellt än vad man tidigare förstått. Detta nya perspektiv, med lysosamer som regulatorer av apoptos, kan stimulera till att söka nya behandlingsstrategier för sjukdomar som beror på ett defekt apoptossystem.

Place, publisher, year, edition, pages
Linköping: Linköping University Electronic Press, 2003. 80 p.
Series
Linköping University Medical Dissertations, ISSN 0345-0082 ; 771
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-28053 (URN)12816 (Local ID)91-7373-528-0 (ISBN)12816 (Archive number)12816 (OAI)
Public defence
2003-01-30, Berzeliussalen, Campus US, Linköpings univeristet, Linköping, 13:00 (English)
Opponent
Available from: 2009-10-08 Created: 2009-10-08 Last updated: 2017-01-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Kågedal, KatarinaJohansson, Ann-CharlotteJohansson, UnoRoberg, KarinÖllinger, Karin

Search in DiVA

By author/editor
Kågedal, KatarinaJohansson, Ann-CharlotteJohansson, UnoRoberg, KarinÖllinger, Karin
By organisation
Experimental PathologyFaculty of Health SciencesOto-Rhiono-Laryngology and Head & Neck Surgery
In the same journal
International journal of experimental pathology (Print)
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 118 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf